M1 Kliniken AG (M12.DE) Stock Analysis & Winston Score
M1 Kliniken AG is a German healthcare company that runs a chain of clinics focused on aesthetic medicine and beauty treatments. Its core services include cosmetic procedures like Botox injections, laser treatments, and other non-surgical beauty services, sold directly to everyday consumers who want to improve their appearance. The company also operates a wholesale distribution business supplying medical and aesthetic products to other healthcare providers across Europe. The company earns money through two main streams: fees paid by patients at its clinics and product sales through its distribution arm. M1 Kliniken operates primarily in Germany and other European markets, with a growing network of clinic locations that gives it some scale advantages over smaller independent providers. With a gross margin of only around 13%, the business runs on thin margins, and its main growth driver is expanding its clinic network — though rising competition in the fast-growing aesthetics market and cost pressures from labor and supplies remain key risks to watch.
Winston Score: 63/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (15/30)
- Growth: Good (13/20)
- Cash Flow: Strong (8/10)
- Stability: Exceptional (10/10)
- Valuation: Mixed (4/10)
- Ownership: Good (10/15)
Key Facts
Price: €18.20
Market Cap: €342M
Sector: Healthcare
Industry: Medical - Care Facilities
Exchange: Frankfurt Stock Exchange


